NOTE: This reminder applies only to "Settling Late Claimants." It does not apply to any other claimants in the Dow Corning case.

If you are a Settling Late Claimant in Class 5 or 6 (Dow Corning breast implant claimants) covered by the Court's Order of December 12, 2007 ("Agreed Order Allowing Late Claimants Limited Rights to Participate in the Plan's Settlement Facility"), then you must submit all claim forms and documents supporting your claims for Explant, Rupture and Disease or Expedited Release by January 21, 2009.

Settling Late Claimants are not allowed to submit a claim for Disease, Rupture or Explant after January 21, 2009. All claim forms for Disease, Rupture and/or Explant must be submitted by January 21, 2009.

If you have questions about your claim, contact the Settlement Facility at their toll-free number: 866-874-6099 or contact them by email at: info@sfdct.com. If you need legal assistance with your claim, you can contact the Claimants' Advisory Committee at info@tortcomm.org.

Detailed information about Atypical Connective Tissue Disease (ACTD) claims is now available on he CAC's website (www.tortcomm.org) or by clicking on the following link: http://www.tortcomm.org/downloads/actdfinalposted_to_website_1-12-09_2.pdf

This is a "pdf" version of the document. It is also available in "Microsoft PowerPoint®" by contacting the Claimants' Advisory Committee at info@tortcomm.org.

The Settlement Facility mailed letters to all claimants who submitted an ACTD claim or who were reviewed for an ACTD claim and who have a deficiency to notify them of their final cure deadline for the ACTD claim. If your cure deadline expired or will expire on or before July 8, 2009, then your new and final cure deadline is July 9, 2009. If you are unable to cure the deficiencies, you can appeal the claim determination to the Claims Administrator, accept payment for any approved compensation level you have been awarded, or elect the Expedited Release payment. It is extremely important that claimants address deficiencies in their claims in a timely way.

Information is currently available on the CAC's website for the 8 other eligible diseases and conditions.

The CAC is working with the Settlement Facility to release one additional document on General Guidelines criteria. We will notify you as soon as this is available.

This is an URGENT REMINDER for all claimants who received a deficiency letter from the Settlement Facility notifying them of their final cure deadline of March 2, 2009 for their ANDS claims. This final deadline only applies to certain ANDS claimants, and all of the affected claimants should have received a notice about the deadine from the Settlement Facility. The deadline does not apply to all ANDS claims or to new claims for ANDS. Claimants can submit new ANDS claims up to the conclusion of the Settlement Plan on June 3, 2019.

The MDL-926 Claims Office has completed its mailings to claimants in the Revised Settlement Program ("RSP") who have a deficiency in their Long Term Benefit disease claim. The mailings concern the end of the Revised Settlement Program, the closing of the MDL-926 Claims Office, and claimants' rights and deadlines in that separate settlement. If you have any questions about your claim in the RSP, contact them at 1-800-600-0311 or visit their website at http://www.claimsoffice-926.com.

The Settlement Facility has announced a new processing protocol that pertains to attorneys and law firms who represent clients who submitted a Class 7 Silicone Gel Material claim and received an award or Cash-Out offer. If the client cannot be located within the six month timeframe that claimants have to accept or reject the $3,000 Disease Cash-Out offer, then the attorney must write to the Settlement Facility and inform them that they could not locate the client within that time frame. The Settlement Facility will use its resources to try and locate the claimant. If the claimant cannot be found, the Settlement Facility will place a hold on the claim until the claimant is either located or the SF-DCT implements a policy to address this issue prior to the closure of the Class 7 Fund. In other words, the attorney will not be required to accept the Disease Cash-out Offer within the six months if they are unable to locate the client.

We have not received any rulings on the other pending motions such as tissue expanders, release disputes, or the Disability A "and/or" issue. We will post any new information about this in our newsletters.

Please mark your calendar with the following claim submission deadlines. Note that different deadlines apply to Notice of Intent (NOI) Claimants and Late Claimants. Please note that most of these deadlines mean that your claim forms and materials must be received by the SF-DCT by the posted deadline. Please mail all forms early enough so that they are received by the deadline listed below. If your claim form is not received by the deadline listed below, you will not be permitted to file a claim later.